Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (LSE/NYSE: HLN) covers the month of May 2025, with a specific reporting date of May 13, 2025. The document serves as a notification and public disclosure under the UK Market Abuse Regulation regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs). Haleon operates as a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report is strictly a regulatory disclosure of insider share transactions and does not contain financial performance data.
Material Changes and Transactions
The filing details two specific transactions executed on May 12, 2025, on the London Stock Exchange (XLON) involving the acquisition of Partnership Shares and the award of Matching Shares under the Company's Share Reward Plan:
- Adrian Morris (General Counsel - PDMR): Acquired 31 Ordinary Shares at a price of £4.03 per share and received 31 Matching Shares at £Nil. Total aggregated volume: 62 shares.
- Tamara Rogers (Chief Marketing Officer - PDMR): Acquired 31 Ordinary Shares at a price of £4.03 per share and received 31 Matching Shares at £Nil. Total aggregated volume: 62 shares.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future performance, risks, contingencies, or unusual items. The document is limited to the disclosure of the specific PDMR transactions listed above.
Investor Verification Checklist
- Verify the total number of shares held by Adrian Morris and Tamara Rogers post-transaction to assess their overall exposure.
- Confirm the current market price of Haleon Ordinary Shares (GB00BMX86B70) relative to the £4.03 transaction price.
- Review the terms of the Company's Share Reward Plan to understand the vesting schedule and conditions for the Matching Shares awarded.
- Check for any subsequent filings that may disclose additional PDMR transactions for the same period.